TF and glioblastoma: Aberrant expression of TF in cancer was reported over four decades ago,7 and has been described in a wide range of solid tumors, including breast, ovarian, prostate, pancreatic, bladder, cervical, esophageal, and colon cancer, HNSCC, NSCLC, and glioblastoma compared to normal tissue8 (Table 1).